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PAGE 107
Carbon nanotubes (CNTs) are remarkable materials that exhibit fascinating physicochem-
ical properties, and their use as tools to investigate biological systems has been gaining
attention and gathering momentum. Incorporating CNTs into routine biological research
will require an integrative approach that crosses disciplines and draws from the efforts of
chemistry, physics, and material and life sciences. In this review, Me´nard-Moyon et al.
provide an overview of recent examples of the use of functionalized CNTs as probes for
molecular functions and highlight the potential of expanding and further developing CNT
based approaches in life sciences. (Figure credit: Me´nard-Moyon et al.)Chemical Synthesis Meets Mycobacterium
tuberculosis
PAGE 117The easy accessibility and availability of a specific substrate is one of the key requirements that needs to be satisfied in order to fully
characterize the kinetics of an enzyme. When that enzyme is IspF, a potential drug target due to its critical role in the 2-C-methyl-D-
erythritol 4-phosphate (MEP) pathway for the biosynthesis of isopentenyl diphosphate and dimethylallyl diphosphate, two major
building blocks of isoprenoid compounds, the need to investigate its kinetics in detail is further emphasized. Here, Narayanasamy
et al. design a synthetic strategy to easily prepare a enantiopure 4-diphosphocytidyl-2-C-methyl-D-erythritol 2-phosphate, IspF
sustrate, and use this compound to initate IspF characterization.Killing Two PI3Ks with One Stone
PAGE 123
Williams et al. describe the discovery of small molecule inhibitors of unusual potency and selectivity for the immune-cell-expressed
PI3Ks d and g. The compounds selectively target PI3Kd and PI3Kg but have over 1000-fold less activity against the ubiquitous PI3Ka
and PI3Kb. The authors discovered that PI3Kd/g dual inhibition provides a more desirable anti-inflammatory profile than either PI3Kd
inhibition alone or pan-PI3K inhibition and uncovered some functional antagonism of further PI3Ka/b inhibition in TNFa release. The
work also revealed a previously unknown level of functional similarity between this dual inhibitory profile and that of the glucocorticoid
agonist prednisolone.Activating TRPML3
PAGE 135
Transient receptor potential (TRP) channels are a large family of ion channels that conduct
cations, including sodium, calcium, and magnesium. TRPML3 is one the family members,
and a study by Grimm et al. now reports on the identification of 53 small molecules that
selectively activate this channel. The compounds activate TRPML3 with different kinetics
and maximal response levels, offering an unprecedented collection of tools to study acti-
vation mechanisms of TRPML3. Surprisingly, cells that natively express TRPML3 showed
only weak or no responses to the activators. These results suggest that TRPML3 in native
cells is either not present in the plasma membrane or that the protein heteromerizes with
other subunits, leading to channels that are not or only weakly responsive to the
compounds identified in this screen. (Figure credit: Grimm et al.)Discovery of Kalimantacin/Batumin-Related
Polyketide Antibiotic
PAGE 149
In the antibiotic resistance age, marked by an increasing need for novel compounds, secondary metabolites continue to play a major
role in antibacterial drug discovery and development. Polyketides represent a major class of antibiotics, amenable to rational anti-
biotic design, by genetic modification within the modular biosynthesis operon. Research by Mattheus et al. focuses on a promising
methicilin-resistant Staphylococcus aureus (MRSA, a critical pathogen in hospital environments) antibiotic, synthesized by a plurality
of polyketide biosynthetic strategies. Analysis of this molecule and its analogs shows its potential and amenability towards engi-
neering with improved activity.Chemistry & Biology 17, February 26, 2010 ª2010 Elsevier Ltd All rights reserved ix
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One of the orphan biosynthetic gene clusters in the 8.2 Mbp genome of the erythromycin-producing bacterium Saccharopolyspora
erythraea encodes a nonribosomal peptide synthetase (ErcD) for the production of erythrochelin, a novel iron-chelating diketopiper-
azine. Remarkably, Lazos et al. now show that the synthesis of erythrochelin also requires the action of a novel acetyltransferase
encoded in a wholly separate gene cluster, in which the resident NRPS is inactivated by a frameshift mutation. Detection of two clus-
ters collaborating to make a single molecule suggests a new factor to consider in future genome mining and sheds an intriguing light
on the evolution of these bacterial pathways.Redesigning Glycosylationx Chemistry & Biology 17, February 26, 2010 ª2010 Elsevier Ltd All rights reservedPAGE 174
Many therapeutic agents are based on glyco-
sylated polyketide and peptide natural prod-
ucts. Alteration of sugar residues within these
compounds can improve pharmacological
properties. This has focused attention on
enzymes that synthesise NDP-linked sugars
and catalyze their transfer to aglycone
acceptors. Here, Hutchinson et al. report
in vivo glycosylation engineering of ampho-
tericin B. A hybrid glycosyltransferase was
shown to modify the aglycone core with
perosamine rather than mycosamine. Thisrepresents the first rational redesign of a polyene glycosyltransferase and defines the GDP-sugar and aglycone-binding domains.
This work will allow further glycorandomization to develop further the antifungal, antiparasitic, and antiviral activities of polyene
macrolides.Ganglioside GD2 Finds Its Small Molecule Ligand
PAGE 183
In this study, Tong et al. combined the use of NMR experiments and molecular modeling to furnish details on the molecular recog-
nition of the ganglioside GD2 by anti-GD2 monoclonal antibody 3F8. Three small peptide ligands of GD2 were designed using the
structural information. Peptide ligands were validated in binding and functional studies and in NMR experiments performed on
GD2-peptide complexes. The work furthers the concept that it is possible to develop small molecule ligands of highly flexible targets
such as carbohydrates and rationalizes that gangliosides may be druggable targets.Targeting a Protein Kinases Inactive Form
PAGE 195
Several protein kinases have been characterized in a specific inactive form called the
DFG-out conformation. This conformation has been targeted by selective type II
inhibitors, including the cancer drugs imatinib and nilotinib. Despite this, the determi-
nants that allow kinases to adopt this conformation are still unknown. Here, Ranjitkar
et al. have identified a general pharmacophore that binds to this DFG-out conforma-
tion of kinases. Fluorophore-conjugated versions of this pharmacophore allow the
determination of the thermodynamics and kinetics of ligand binding to the kinase
catalytic domain. In addition, immobilized analogs of the general scaffold are effective
reagents for enriching DFG-out-adopting kinases from cell lysates. (Figure credit:
Ranjitkar et al.)
